Michael R McAlevey sold $904k of HCA
EVP & Chief Legal & Admin Off. at HCA Healthcare, Inc.. 1,694 shares at an average of $533.37, traded Feb 18, 2026, filed Feb 18, 2026.
Score components
- +15RoleOfficer
- +24Trade size$904k at market
- +5Share of holdings soldSold 16% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.6%, 3m -25.7%, 6m -23.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-057701, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | MOption exercise Common Stock | +5,000 | $236.61 | $1.2M | 13,853 | Feb 18, 2026 |
| Feb 13, 2026 | FTax withholding Common Stock | -3,306 | $540.29 | $1.8M | 10,547 | Feb 18, 2026 |
| Feb 18, 2026 | SOpen-market sale Common Stock | -1,694 | $533.37 | $904k | 8,853 | Feb 18, 2026 |
| Feb 13, 2026 | MOption exercise Stock Appreciation Rightderivative | -5,000 | $0.00 | $0 | 8,860 | Feb 18, 2026 |
Related signals
Other insiders at HCA Healthcare, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 65Notable | HCA Healthcare, Inc. | Jennifer Berres SVP & Chief Human Res. Officer | $4.1M 8,020 shares | -40% | |
| 55Moderate | HCA Healthcare, Inc. | Christopher F. Wyatt SVP & Controller | $2.0M 4,000 shares | -8% | |
| 51Moderate | HCA Healthcare, Inc. | Michael S. Cuffe EVP and Chief Clinical Officer | $747k 1,500 shares | -5% | |
| 85Strong | HCA Healthcare, Inc. | Samuel N Hazen CEO | $21M 42,877 shares | -57% | |
| 45Moderate | HCAsell HCA Healthcare, Inc. | Michael R McAlevey EVP & Chief Legal & Admin Off. | $1.8M 3,892 shares | -53% | |
| 10Weak | HCA Healthcare, Inc. | Michael S. Cuffe EVP and Chief Clinical Officer | $1.6M 3,836 shares | -11% | |
| 65Notable | HCAsell HCA Healthcare, Inc. | Jon M Foster EVP and COO | $5.8M 15,698 shares | -55% | |
| 24Weak | HCAbuy HCA Healthcare, Inc. | Bank Of America Corp /de/ owner | $88k 3,436 shares | - | |
| 41Moderate | HCAsell HCA Healthcare, Inc. | Bank Of America Corp /de/ owner | $80k 3,178 shares | -666% | |
| 50Moderate | HCAsell HCA Healthcare, Inc. | Jennifer Berres SVP & Chief Human Res. Officer | $3.1M 9,533 shares | -38% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.